Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04767087
Status:
UNKNOWN
Last Update Posted:
2021-07-02
First Post:
2021-02-20
Brief Title:
Honey and Nigella Sativa in COVID-19 Prophylaxis
Sponsor:
Sohaib Ashraf
Organization:
Sheikh Zayed Federal Postgraduate Medical Institute
Study Overview
Official Title:
Honey and Nigella Sativa in the Prophylaxis of COVID-19 A Randomized Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2021-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HNS-COVID-PK
Brief Summary:
Honey and Nigella sativa has established antiviral antibacterial anti-inflammatory and immunomodulatory roles So it is planned to test for its prophylaxis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None